Screening for Gestational Diabetes Mellitus by Measuring Glycated Hemoglobin Can Reduce the Use of the Glucose Challenge Test
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Physiological changes during pregnancy, such as dilutional anemia and a reduced half-life of red blood cells, have prevented the use of glycated Hb (HbA1c) as a biomarker for gestational diabetes mellitus (GDM). Nevertheless, increasing evidence supports the use of HbA1c in GDM diagnostic strategies.We studied HbA1c as a biomarker of GDM and its possible use as a screening test to avoid the use of the glucose challenge test (GCT). Methods: This case-control study involved 607 pregnant women between the 24th and 28th week of gestation. HbA1c level was determined, and GDM was diagnosed according to the National Diabetes Data Group criteria. The area under the ROC curve (AUC) was determined; two low and two high cut-off points were established to rule out GDM and classify high-risk pregnant women, respectively. For each cut-off, sensitivity (S), specificity (SP), and total number and percentage of GCTs avoided were determined. Results: The AUC for HbA1c diagnostic performance was 0.68 (95% confidence interval 0.57–0.79). Using 4.6% HbA1c (27 mmol/mol) as the lower cut-off (S=100%), 14% of participants could avoid the GCT. Using 5.5% HbA1c (36 mmol/mol) as the upper cut-off (SP =94.5%), 6% of participants would be considered at high risk. Conclusions: HbA1c can be used as a screening test prior to the GCT, thereby reducing the need for the GCT among pregnant women at a low risk of GDM.
Abstract
Background: Physiological changes during pregnancy, such as dilutional anemia and a reduced half-life of red blood cells, have prevented the use of glycated Hb (HbA1c) as a biomarker for gestational diabetes mellitus (GDM). Nevertheless, increasing evidence supports the use of HbA1c in GDM diagnostic strategies.We studied HbA1c as a biomarker of GDM and its possible use as a screening test to avoid the use of the glucose challenge test (GCT). Methods: This case-control study involved 607 pregnant women between the 24th and 28th week of gestation. HbA1c level was determined, and GDM was diagnosed according to the National Diabetes Data Group criteria. The area under the ROC curve (AUC) was determined; two low and two high cut-off points were established to rule out GDM and classify high-risk pregnant women, respectively. For each cut-off, sensitivity (S), specificity (SP), and total number and percentage of GCTs avoided were determined. Results: The AUC for HbA1c diagnostic performance was 0.68 (95% confidence interval 0.57–0.79). Using 4.6% HbA1c (27 mmol/mol) as the lower cut-off (S=100%), 14% of participants could avoid the GCT. Using 5.5% HbA1c (36 mmol/mol) as the upper cut-off (SP =94.5%), 6% of participants would be considered at high risk. Conclusions: HbA1c can be used as a screening test prior to the GCT, thereby reducing the need for the GCT among pregnant women at a low risk of GDM.
참고문헌 (25)
- International Association of Diabetes, "International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy", Diabetes Care, 33, pp.676~682 (2010)
- HAPO Study Cooperative Research Group, "Hyperglycemia and adverse pegnancyoutcomes", New Engl J Med, 358, pp.1991~2002 (2008)
- Farrar D, "Different strategies for diagnosing gestational diabetes to improve maternal and infant health", Cochrane Database Syst Rev, 1, pp.CD007122~ (2015)
- American Diabetes Association, "Management of diabetes in pregnancy: standards of medical care in diabetes - 2019", Diabetes Care, 42(S1), pp.S165~S172 (2019)
- Committee on Practice Bulletins - Obstetrics, "Practice Bulletin No. 137: Gestational diabetes mellitus", ObstetGynecol, 122, pp.406~416 (2013)
- Donovan L, "Screening tests for gestational diabetes : a systematic review for the US Preventive Services Task Force", Ann Intern Med, 159, pp.115~122 (2013)
- Bonongwe P, "Reproducibility of a 75G oral glucose tolerance test in pregnant women", J Perinat Med, 43, pp.333~338 (2015)
- Maesa JM, "Evaluation of Bio-Rad D-100 HbA1c analyzer against Tosoh G8 and Menarini HA-8180V", Pract Lab Med, 5, pp.57~64 (2016)
- Use of glycated haemoglobin (HbA1c) in diagnosis of diabetes mellitus: abbreviated report of a WHO consultation, "WHO", 1~25 (2011)
- International Expert Committee, "International expert committee report on the role of the A1C assay in the diagnosis of diabetes", Diabetes Care, 32, pp.1327~1334 (2009)
- Lowe LP, "Hyperglycemia and adverse pregnancy outcome(HAPO)Study : associations of maternal A1C and glucose with pregnancy outcomes", Diabetes Care, 35, pp.574~580 (2012)
- Maesa JM, "Application of six sigma model to evaluate the analytical quality of four HbA1c analyzers", Clin Lab, 63, pp.79~83 (2017)
- GrupoEspañol Diabetes y Embarazo, "Asistencia a la gestante con diabetes. Guía de prácticaclínicaactualizadaen 2014", Diabetologia, 31, pp.45~59 (2015)
- National Diabetes Data Group, "Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance", Diabetes, 28, pp.1039~1057 (1979)
- Renz PB, "HbA1c test as a tool in the diagnosis of gestational diabetes mellitus", PLoS One, 10, pp.e0135989~ (2015)
- Agarwal MM, "Gestational diabetes screening of a multiethnic, high-risk population using glycated proteins", Diabetes Res ClinPract, 51, pp.67~73 (2001)
- "Plan integral de diabetes en Andalucía. Análisissituación 2013" (2013)[URL]
- Benhalima K, "Screening for gestational diabetes in Europe : where do we stand and how to move forward : A scientific paper commissioned by the European Board & College of Obstetrics and Gynaecology(EBCOG)", Eur J ObstetGynecolReprodBiol, 201, pp.192~196 (2016)
- National Institute for Health and Care Excellence, "Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period", 2~65 (2015)
- Aceituno Velasco L, "Procesoasistencialintegradoembarazo, parto y puerperio", Junta Andalucía ConserjeríaIgualdad, Salud u PolíticasSoc, 3, pp.1~73 (2014)
- Carpenter MW, "Criteria for screening tests for gestational diabetes", Am J ObstetGynecol, 144, pp.768~773 (1982)
- Kwon SS, "HbA1c for diagnosis and prognosis of gestational diabetes mellitus", Diabetes Res ClinPract, 110, pp.38~43 (2015)
- Khalafallah A, "Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus", BMJ Open, 6, pp.e011059~ (2016)
- Ye M, "The utility of HbA1c for screening gestational diabetes mellitus and its relationship with adverse pregnancy outcomes", Diabetes Res ClinPract, 114, pp.43~49 (2016)
- Wolfenbuttel BH, "Ethnic differences in glycemic markers in patients with type 2 diabetes", Diabetes Care, 36, pp.2931~2936 (2013)